Screener
Corcept Therapeutics CORT PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Corcept Therapeutics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050613
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Total current assets | 439,676 | 485,464 |
| Strategic inventory | 18,956 | 11,094 |
| Operating lease right-of-use asset | 6,860 | 4,583 |
| Property and equipment, net | 5,133 | 1,890 |
| Long-term marketable securities | 236,451 | 160,270 |
| Other assets | 2,946 | 5,153 |
| Deferred tax assets, net | 178,680 | 168,197 |
| Total assets | $888,702 | $836,651 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Corcept Therapeutics's PP&E (net)?
- Corcept Therapeutics (CORT) reported PP&E (net) of $5.13M in Q2 2026.
- How has Corcept Therapeutics's PP&E (net) changed year-over-year?
- Corcept Therapeutics's PP&E (net) increased by 118.6% year-over-year, from $2.35M to $5.13M.
- What is the long-term trend for Corcept Therapeutics's PP&E (net)?
- Over 5 years (2020 to 2025), Corcept Therapeutics's PP&E (net) has grown at a 2.4% compound annual growth rate (CAGR), from $1.68M to $1.89M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Corcept Therapeutics's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude